Abbott Laboratories (NYSE:ABT)

59.19
Delayed Data
As of Apr 20
 -0.69 / -1.15%
Today’s Change
42.88
Today|||52-Week Range
64.60
+3.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line283.0M603.0M-828.0M--
 
 
 
 
Depreciation648.0M756.0M843.0M--
 
 
 
 
Total Other Cash Flow522.0M93.0M142.0M--
 
 
 
 
Funds From Operations1.5B1.5B157.0M--
 
 
 
 
Extraordinary Items0.00-12.0M0.00--
 
 
Funds From/For Other Operating Expenses102.0M-565.0M-1.5B--
 
 
 
 
Net Cash Flow - Operating Activities1.4B2.0B1.6B--
 
 
 
 
 
InvestingIncrease In Investments-13.0M-70.0M-112.0M--
 
 
 
 
Decrease In Investments239.0M53.0M856.0M--
 
 
 
 
Capital Expenditures-255.0M-263.0M-345.0M--
 
 
 
 
Fixed Asset Disposal-1.0M-29.0M600.0M--
 
 
 
 
Net Assets From Acquisitions 0.000.00-4.2B--
 
 
Other Investing - Sources24.0M3.0M5.0M--
 
 
 
 
Net Cash Flow Investing-6.0M-306.0M-3.2B--
 
 
 
 
 
FinancingShort Term Borrowings26.0M5.0M390.0M--
 
 
 
 
Long Term Borrowings0.00-8.0M6.8B--
 
 
 
Long Term Debt Reduction-2.0M-1.0M-6.1B--
 
 
 
 
Net Proceeds Stock Sale57.0M89.0M75.0M--
 
 
 
 
Common Preferred Redeemed-3.0M-8.0M-721.0M--
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-462.0M-463.0M-464.0M--
 
 
 
 
Other Sources - Financing----------
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing-384.0M-386.0M-112.0M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash8.0M24.0M19.0M--
 
 
 
 
 
Net Change In Cash961.0M1.3B-1.6B0.00